Article Text

PDF

743 Lysosomal Storage Disorders in Non-Immunological Hydrops Fetalis - More Common than Assumed?
  1. C Whybra1,
  2. E Mengel2,
  3. F Bahlmann3,
  4. C Kampmann4,
  5. M Beck2,
  6. E Mildenberger1
  1. 1Neonatology
  2. 2Department of Lysosomal Storage Disorder, Villa Metabolica, University Medical Center of the Johannes Gutenberg University, Mainz
  3. 3Department of Obstetrics and Gynecology, Buergerhospital, Frankfurt/Main
  4. 4Department of Pediatric Cardiology, Medical Center of the Johannes Gutenberg University, Mainz, Germany

Abstract

Background Although non immunological hydrops fetalis (NIHF) is a very rare disorder, the disturbance accounts for a disproportionate share (3%) of overall mortality in the perinatal period. Lysosomal storage disorders (LSD) are only exceptionally considered to be the cause of NIHF. The reported incidence is about 1%. On the other hand, in about 18% of all cases, NIHF is classified as idiopathic.

Patients and methods We report four cases of transient NIHF due to LSD and reviewed the literature for LSD associated with NIHF.

Results At present, 12 different LSD are described to be associated with NIHF. The majority of reported patients already had a family history of NIHF, which had not been investigated. A diagnostic approach to the fetus with NIHF due to suspected LSD is suggested.

Conclusions Extensive and thorough investigation of the etiology of NIHF is obligatory. In particular, LSD should be considered in idiopathic NIHF. Enzymatic studies in chorionic villous samples or amniotic cultured cells, once the most common conditions associated with NIHF have been ruled out, should be performed. We assume that the incidence of LSD in NIHF is significantly higher than the estimated 1% reported in previous studies. This is important for genetic counseling, as there is at first, a high risk of recurrence and, secondly, the availability of enzyme replacement therapy for an increasing number of LSD.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.